genOway | ALGEN FP | Biomedical-Genetics | France

This research has been commissioned and paid for by the company and does therefore not constitute an inducement caught by the prohibition under MiFID II

In a nutshell
Businesses & Trends
Money Making
Debt
Valuation
Financials
Pension Risks
Sustainability / ESG
Worth Knowing
Graphs
Snapshot Full Pdf

genOway ^CR	Bloomberg ALGEN FP
Biomedical-Genetics / France	Web Site \| Investors Relation

We have stopped researching genOway from 1 September 2019.